Triple-Negative Breast Cancer Research and Education Act of 2023 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
To provide for a limitation on availability of funds for Department of State, International Narcotics Control and Law Enforcement for fiscal year 2024.
To provide for a limitation on availability of funds for Department of State, Nonproliferation, Anti-Terrorism, Demining and Related Programs for fiscal year 2024.
To provide for a limitation on availability of funds for Contribution to the International Bank for Reconstruction and Development for fiscal year 2024.
This bill requires the Department of Veterans Affairs (VA) to designate one week per year as Battle Buddy Check Week for the purposes of organizing outreach events and educating veterans on how to conduct peer wellness checks. The VA shall ensure that the Veterans Crisis Line has a plan for handling the potential increase in calls that may occur during such week.